Armenia vs Europe (WHO region): Previously treated cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Europe (WHO region)
90.0%
in 2024
Armenia rank
1st
Europe (WHO region) rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Armenia
- Europe (WHO region)
How they compare
Armenia currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Armenia's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 4 times across 20 shared years of data; in 2005 it was Armenia ahead.
Armenia ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Europe (WHO region) in 1.
Head to head by decade
| Decade | Armenia | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.4% | 20.2% | 24.2% | Armenia |
| 2010s | 39.7% | 57.7% | 18.0% | Europe (WHO region) |
| 2020s | 98.4% | 93.8% | 4.6% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Armenia or Europe (WHO region)?
- Armenia, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Armenia and Europe (WHO region)?
- 10.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Europe (WHO region)?
- 20 years are reported by both, from 2005 to 2024.
- How do Armenia and Europe (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.